YEVHENIYA KHROBUST: Open Payments
NPI 1013528488 · LA JOLLA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,276 in 174 payments from 27 companies in 2025. Trend: 2023 $401 · 2024 $7,539 · 2025 $4,276
Food & beverage: $4,276
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 23 | $867 |
| ABBVIE INC. | 41 | $762 |
| SK Life Science, Inc. | 23 | $546 |
| PFIZER INC. | 20 | $241 |
| LivaNova USA, Inc. | 1 | $235 |
| Lundbeck LLC | 9 | $204 |
| Neurocrine BioSciences, Inc. | 11 | $180 |
| Teva Pharmaceuticals USA, Inc. | 10 | $158 |
| Biogen, Inc. | 5 | $128 |
| Axsome Therapeutics, Inc. | 1 | $121 |
Products named: Fintepla, BOTOX, QULIPTA, NURTEC ODT, VNS Therapy, VYEPTI, INGREZZA, Zilbrysq.
Industry payments across CA — which companies pay providers there.
